Cargando…
Macrophage-targeted nanomedicine for the diagnosis and management of atherosclerosis
Atherosclerosis is the primary cause of cardiovascular diseases, such as myocardial infarction and stroke, which account for the highest death toll worldwide. Macrophage is the major contributor to atherosclerosis progression, and therefore, macrophage-associated pathological process is considered a...
Autores principales: | Hu, Ping Ping, Luo, Shuang Xue, Fan, Xiao Qing, Li, Di, Tong, Xiao Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501673/ https://www.ncbi.nlm.nih.gov/pubmed/36160452 http://dx.doi.org/10.3389/fphar.2022.1000316 |
Ejemplares similares
-
Editorial: Advances on targeted nanomedicines for atherosclerosis
por: Han, Qinggong, et al.
Publicado: (2022) -
Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis
por: Chen, Wei, et al.
Publicado: (2021) -
Advanced targeted nanomedicines for vulnerable atherosclerosis plaque imaging and their potential clinical implications
por: Li, Xue, et al.
Publicado: (2022) -
Functional Nanomedicines for Targeted Therapy of Bladder Cancer
por: Tang, Chao, et al.
Publicado: (2021) -
Macrophage Death as a Pharmacological Target in Atherosclerosis
por: Martinet, Wim, et al.
Publicado: (2019)